Suicide drug gets FDA fast track
September 8, 2017
NeuroRx, a Wilmington biopharmaceutical company, has been granted fast-track status by the U.S. Food and Drug Administration for an experimental treatment for suicidal behavior. The company will begin enrolling patients […]
chat_bubble0 Comment
visibility646 Views
Premier Digital Partners
© 2024 Delaware Business Times
